David M Kurnit

Title: David M Kurnit: Innovator in HPV Detection and Quantitative PCR

Introduction

David M Kurnit is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of biological detection, particularly in the area of human papillomavirus (HPV) and quantitative PCR methods. With a total of two patents to his name, Kurnit's work has implications for cancer detection and management.

Latest Patents

Kurnit's latest patents include "Systems, methods, and compositions for detection of human papilloma virus in biological samples." This invention focuses on the detection, identification, and quantification of HPV in various biological samples, which is crucial for cancer treatment and management. His second patent, "Quantitative PCR using blocking oligonucleotides," discloses a method for determining the number of copies of a target nucleic acid in a biological specimen. This method involves amplifying both the target and reference nucleic acids and comparing their amplification levels.

Career Highlights

Throughout his career, Kurnit has worked with reputable organizations such as Biotronics, Inc. and the University of Michigan. His experience in these institutions has allowed him to develop innovative solutions in the field of biological research.

Collaborations

Kurnit has collaborated with notable colleagues, including Pei-Wen Chiang and Chang-Ning J Wang. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

David M Kurnit is a distinguished inventor whose work in HPV detection and quantitative PCR has the potential to impact cancer diagnostics significantly. His contributions to the field exemplify the importance of innovation in medical research.